Location History:
- Burnham, EN (1976)
- Burnham, GB (1989 - 1990)
Company Filing History:
2 out of 299 
1 out of 1,567 
1 out of 1 Years Active: 1976-1990
Title: Innovation and Contributions of Inventor Kenneth Heatherington
Introduction
Kenneth Heatherington, an accomplished inventor based in Burnham, GB, has made significant contributions to the field of chemistry with a total of four patents to his name. His innovative work primarily focuses on quinoline derivatives, which play a crucial role in developing compounds with anti-ulcer and anti-inflammatory properties.
Latest Patents
Kenneth's latest patents involve the creation of quinoline derivatives, which include complex compound formulas designed to address medical needs. One of the notable inventions concerns a compound represented by formula II, which features various radicals that can be substituted to create effective intermediates for compounds exhibiting anti-ulcer activity. Additionally, another patent focuses on a compound of formula III, which also serves as intermediates for compounds with anti-ulcer and anti-secretory activities, further showcasing the versatility of his inventions.
Career Highlights
Throughout his career, Kenneth has had the opportunity to work with esteemed organizations, including John Wyeth & Brother Limited and American Home Products Corporation. His experiences in these companies have contributed to his growth as an inventor and his ability to develop groundbreaking solutions in the pharmaceutical space.
Collaborations
Collaboration has been a key aspect of Kenneth's career. He has worked alongside notable coworkers, including Roger Crossley and John Leheup Archibald. These partnerships have facilitated the exchange of ideas and knowledge, which is essential in fostering innovation and advancing research in the field.
Conclusion
Kenneth Heatherington's contributions to the realm of quinoline derivatives and his dedication to addressing medical challenges highlight his importance as an inventor. With a total of four patents and a strong career history, Kenneth continues to pave the way for future innovations in the pharmaceutical industry. His work not only exemplifies creativity but also reflects a commitment to improving health outcomes through scientific advancements.